Literature DB >> 10441181

Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome.

E C Kolkowski1, P Reth, F Pelusa, J Bosch, R Pujol-Borrell, J Coll, D Jaraquemada.   

Abstract

Objectives of this study were to examine the cytokine and perforin mRNA expression in minor salivary glands from patients with primary Sjögren's syndrome (pSS), searching for possible correlation with clinical parameters and to identify the dominant cytokine pattern in the different groups. Oral mucosa biopsy samples from 42 pSS patients were studied. Total RNA was analysed by normalized RT-PCR using oligo-dT as the RT primer and IL-2, IFN-gamma, IL-12, IL-18, IL-4, IL-10, TGF-beta, TNF-alpha and perforin-specific primers for amplification. Results were analysed taking into account: (1) biopsy grade I to IV (Chisholm's classification); (2) diagnosis of either definite pSS (n=30) or probable pSS (n=12), following the European classification criteria (ECC), and (3) length of disease evolution from the beginning of symptoms to the time of biopsy, using an arbitrary cut-off point of 12 months. This studied showed that Th1-related cytokines (IL-2, IFN-gamma, IL-12, IL-18, TNF-alpha) and perforin were present in most samples. IL-4 (Th2) was totally absent but other Th2 and regulatory cytokines (IL-10, TGF-beta) were detected in the majority of samples. No significant differences were found between definite and probable pSS nor between grades II, III, IV and fibrous tissue biopsies. A statistically significant increase of IL-2 (P=0.012) and IFN-gamma (P=0.019) was observed in samples from patients with longer disease evolution, whereas the two Th1-inducer cytokines IL-12 and IL-18 were equally and highly expressed in all samples. In conclusion, a predominant Th1 pattern of cytokines was observed in all pSS samples, irrespective of biopsy classification. In addition, a significant increase of Th1 cytokine expression frequency was associated with longer disease evolution. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10441181     DOI: 10.1006/jaut.1999.0289

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  18 in total

1.  The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome.

Authors:  D I Mitsias; A G Tzioufas; C Veiopoulou; E Zintzaras; I K Tassios; O Kogopoulou; H M Moutsopoulos; G Thyphronitis
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

2.  Upregulation of long noncoding RNA TMEVPG1 enhances T helper type 1 cell response in patients with Sjögren syndrome.

Authors:  Juan Wang; Huiyong Peng; Jie Tian; Jie Ma; Xinyi Tang; Ke Rui; Xinyu Tian; Yungang Wang; Jianguo Chen; Liwei Lu; Huaxi Xu; Shengjun Wang
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

Review 3.  Current status of gene delivery and gene therapy in lacrimal gland using viral vectors.

Authors:  Shivaram Selvam; Padmaja B Thomas; Sarah F Hamm-Alvarez; Joel E Schechter; Douglas Stevenson; Austin K Mircheff; Melvin D Trousdale
Journal:  Adv Drug Deliv Rev       Date:  2006-09-15       Impact factor: 15.470

4.  Current Aspects of Pathogenesis in Sjögren's Syndrome.

Authors:  Michael Voulgarelis; Athanasios G Tzioufas
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-12       Impact factor: 5.346

Review 5.  Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome.

Authors:  Michael Voulgarelis; Athanasios G Tzioufas
Journal:  Nat Rev Rheumatol       Date:  2010-08-03       Impact factor: 20.543

6.  Unique glandular ex-vivo Th1 and Th17 receptor motifs in Sjögren's syndrome patients using single-cell analysis.

Authors:  Alexandria Voigt; Katherine Bohn; Sukesh Sukumaran; Carol M Stewart; Indraneel Bhattacharya; Cuong Q Nguyen
Journal:  Clin Immunol       Date:  2018-04-19       Impact factor: 3.969

7.  TLR3-mediated apoptosis and activation of phosphorylated Akt in the salivary gland epithelial cells of primary Sjögren's syndrome patients.

Authors:  Hideki Nakamura; Yoshiro Horai; Takahisa Suzuki; Akitomo Okada; Kunihiro Ichinose; Satoshi Yamasaki; Takehiko Koji; Atsushi Kawakami
Journal:  Rheumatol Int       Date:  2012-03-29       Impact factor: 2.631

8.  Decrease of blood dendritic cells and increase of tissue-infiltrating dendritic cells are involved in the induction of Sjögren's syndrome but not in the maintenance.

Authors:  Y Ozaki; T Ito; Y Son; H Amuro; K Shimamoto; H Sugimoto; Y Katashiba; M Ogata; R Miyamoto; N Murakami; R Amakawa; S Fukuhara
Journal:  Clin Exp Immunol       Date:  2009-12-14       Impact factor: 4.330

9.  Relationship between serum levels of IL-18 and IgG1 in patients with primary Sjögren's syndrome, rheumatoid arthritis and healthy controls.

Authors:  P Eriksson; C Andersson; C Ekerfelt; J Ernerudh; T Skogh
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

Review 10.  Cytokines in Sjögren's syndrome.

Authors:  N Roescher; P P Tak; G G Illei
Journal:  Oral Dis       Date:  2009-06-10       Impact factor: 3.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.